Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Fate Therapeutics Inc. buy Wedbush

Fate Therapeutics Inc.
Start price
€1.35
27.10.25 / 50%
Target price
€6.02
27.10.26
Performance (%)
77.55%
Price
€2.39
10.08.26
Summary
This prediction is currently active. The BUY prediction by Wedbush for Fate Therapeutics Inc. has seen massive gains of 77.55%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Fate Therapeutics Inc. 10.556% 10.556%
iShares Core DAX® 1,00 % 4,83 %
iShares Nasdaq 100 2,70 % -1,72 %
iShares Nikkei 225® 3,52 % -3,51 %
iShares S&P 500 1,77 % 1,27 %

Comments by Wedbush for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 77.55%
Target price 6.015
Change
Ends at 27.10.26

Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat

Wedbush 
0
Report Share
27.10.25